The effectiveness of aromatherapy inhaler on irritable bowel syndrome (IBS) patients.
Phase 2
- Conditions
- Irritable bowel syndrome.Irritable bowel syndrome
- Registration Number
- IRCT2016123031663N1
- Lead Sponsor
- Vice Chancellor for Research, Mashhad University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 60
Inclusion Criteria
Aged between 15 and 60 years; Abdominal pain or discomfort at least three days a month in the past three months; patients with mild-to-moderate IBS; Lack of nasal polyps (NP) or deviated nasal septum (DNS) disease; Having cranial nerve activity with examination; Lack of specific psychiatric diagnoses which led him to be hospitalized.
Exclusion criteria: Failure to use the correct fragrance; Drugs, tobacco or hookah addiction; Allergic reaction to essential oils; Using complementary or alternative medicine; Having allergic rhinitis and respiratory diseases.
Exclusion Criteria
Not provided
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Clinical outcomes including pain frequency, pain duration, poop's consistency, defecation frequency, etc. Timepoint: 4 weeks after intervention. Method of measurement: Questionnaire.
- Secondary Outcome Measures
Name Time Method